Steward Partners Investment Advisory’s Neurotrope, Inc. Common NTRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-1,491
Closed -$1K – 3546
2020
Q4
$1K Sell
1,491
-1,407
-49% -$1.46K ﹤0.01% 2854
2020
Q3
$3K Hold
2,898
– – ﹤0.01% 2547
2020
Q2
$3K Hold
2,898
– – ﹤0.01% 2449
2020
Q1
$2K Hold
2,898
– – ﹤0.01% 2346
2019
Q4
$2K Hold
2,898
– – ﹤0.01% 2468
2019
Q3
$2K Hold
2,898
– – ﹤0.01% 2479
2019
Q2
$23K Buy
+2,898
New +$19.5K ﹤0.01% 1664

Steward Partners Investment Advisory's NTRP Position: Q1 2021 in Review

Steward Partners Investment Advisory sold out of Neurotrope, Inc. Common (NTRP) in Q1 2021, closing a stake of 1,491 shares — an estimated $1K sold.

Steward Partners Investment Advisory first reported a position in NTRP in Q2 2019 and held it in 7 quarters. The position peaked at $23K in Q2 2019. 0 funds tracked by Wall St. Rank hold NTRP as of Q1 2021.

  • Steward Partners Investment Advisory reported no remaining Neurotrope, Inc. Common position as of Q1 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,491 Neurotrope, Inc. Common shares in Q1 2021, an estimated $1K.
  • Steward Partners Investment Advisory first reported a position in Neurotrope, Inc. Common in Q2 2019 and held it in 7 quarters.
  • Steward Partners Investment Advisory's Neurotrope, Inc. Common position peaked at $23K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q1 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2021, filed 14 May 2021.